Key facts
- Notable investors include National University of Singapore.
- Status: Privately Held (backing).
Investors
1- ·The complete investor list — 1 names
- ·Watchlist + deal alerts for B1Neuro
- ·The full record, as it builds
Funding rounds
No funding rounds for B1Neuro are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About B1Neuro
Operator of a neurotargeting platform intended to provide personalized brain stimulation treatment. The company offers advanced neuroimaging analysis, individualized brain mapping, and precise stimulation targeting, enabling clinicians and patients to enhance treatment accuracy and achieve improved therapeutic outcomes in neurological care.
- Sector
- Healthcare
- HQ
- Singapore, Singapore
- Employees
- 2
- Website
- b1neuro.com/
- Ownership
- Privately Held (backing)
B1Neuro doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in B1Neuro shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on B1Neuro in its N-PORT filings yet. We sweep new filings monthly.